BEUDAMED
    101 results · 16ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Solid Tumors with dMMR status)

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (TIPS/LLIAC/VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS VENOUS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous RP & Endoprosthesis with Unistep Plus

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (TIPS,ILAC,VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS (VENOUS)

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)